Related Experiment Video
Updated: Jun 17, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[Pre-exposure prophylaxis in HIV--a vision or soon a reality?]
S Reuter1, D Meyer, H Knechten
1Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf. stefan.reuter@med.uniduesseldorf.de
Pre-Exposure Prophylaxis (PrEP) using antiretroviral drugs is being explored as an alternative HIV prevention method when condoms are not used. Clinical studies are ongoing, with results expected soon to determine PrEP's efficacy and integration into public health strategies.
Area of Science:
- Virology
- Public Health
- Pharmacology
Context:
- Condom use remains the primary HIV prevention method, but inconsistent application necessitates alternative strategies.
- Pre-Exposure Prophylaxis (PrEP) involves antiretroviral drug intake before potential HIV exposure.
- Animal models show efficacy for Tenofovir and Emtricitabine combination for HIV-PrEP.
Purpose:
- To evaluate the potential of Pre-Exposure Prophylaxis (PrEP) as a supplementary HIV prevention strategy.
- To explore the challenges and considerations for implementing PrEP in healthcare systems.
- To anticipate the interdisciplinary questions surrounding PrEP's use and regulation.
Summary:
- Clinical trials are underway globally to assess the efficacy of HIV-PrEP in various at-risk populations.
- Antiretroviral drugs like Tenofovir and Emtricitabine are being studied for their prophylactic effects.
- Early results are anticipated in 2010, with potential implications for HIV prevention.
Impact:
- Successful PrEP implementation requires careful recipient selection and measures to prevent drug resistance and misuse.
- PrEP is unlikely to offer absolute protection or replace existing prevention methods but may serve as a valuable addition.
- Addressing epidemiological, behavioral, logistical, political, and ethical questions is crucial before widespread PrEP adoption.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Respiratory Syncytial Virus Disease
Inhibitors of Virion Maturation and Assembly
Sexually Transmitted Infections
Cryptococcal Meningitis

